NCT01861964View on ClinicalTrials.gov

Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
BifidobacteriaHealthy Volunteers
Interventions
DIETARY_SUPPLEMENT

Placebo (Maltodextrin)

Maltodextrin 505mg/capsule 8 capsules/day (4 with breakfast and 4 with dinner meal)

DIETARY_SUPPLEMENT

Xylooligosarcharide 1.4g

8 capsules (512 mg/capsule) 4 with breakfast and 4 with dinner meal

DIETARY_SUPPLEMENT

Xylooligosarcharide 2.8g

8 capsules (520 mg/capsule) to be taken in the morning and in the evening

Trial Locations (2)

90095

UCLA Center for Human Nutriiton, Los Angeles

UCLA Center for Human Nutrition, David Geffen School of Medicine, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT01861964 - Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora | Biotech Hunter | Biotech Hunter